HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stamatios Theocharis Selected Research

Ephrins

5/2022The EPH/Ephrin System in Bone and Soft Tissue Sarcomas' Pathogenesis and Therapy: New Advancements and a Literature Review.
4/2022EPHA2, EPHA4, and EPHA6 Expression in Uveal Melanomas: Searching for the Culprits of Neoplasia.
3/2022Utilizing Exosomal-EPHs/Ephrins as Biomarkers and as a Potential Platform for Targeted Delivery of Therapeutic Exosomes.
3/2022The EPH/Ephrin System in Gynecological Cancers: Focusing on the Roots of Carcinogenesis for Better Patient Management.
3/2022The EPH/Ephrin System in Colorectal Cancer.
2/2022EPHA2, EPHA4, and EPHA7 Expression in Triple-Negative Breast Cancer.
8/2021The Clinical Impact of the EPH/Ephrin System in Cancer: Unwinding the Thread.
10/2018Viewing the Eph receptors with a focus on breast cancer heterogeneity.
4/2014Ephrin receptor (Eph) -A1, -A2, -A4 and -A7 expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival.
2/2014Ephrin (Eph) receptor A1, A4, A5 and A7 expression in human non-small cell lung carcinoma: associations with clinicopathological parameters, tumor proliferative capacity and patients' survival.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stamatios Theocharis Research Topics

Disease

110Neoplasms (Cancer)
07/2022 - 06/2002
22Carcinogenesis
06/2022 - 12/2008
15Neoplasm Metastasis (Metastasis)
03/2022 - 09/2007
12Inflammation (Inflammations)
06/2022 - 09/2009
11Adenocarcinoma
07/2019 - 06/2002
10Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2017 - 02/2011
9Colonic Neoplasms (Colon Cancer)
11/2019 - 06/2002
8Carcinoma (Carcinomatosis)
10/2021 - 06/2002
8Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2019 - 06/2002
7Breast Neoplasms (Breast Cancer)
02/2022 - 01/2012
7Reperfusion Injury
05/2021 - 09/2008
6Pancreatic Neoplasms (Pancreatic Cancer)
09/2021 - 05/2009
5Colorectal Neoplasms (Colorectal Cancer)
03/2022 - 10/2009
4Pituitary Neoplasms (Pituitary Adenoma)
09/2022 - 12/2008
4Endometrial Neoplasms (Endometrial Cancer)
03/2022 - 01/2013
4Melanoma (Melanoma, Malignant)
03/2022 - 05/2021
4Lung Neoplasms (Lung Cancer)
08/2018 - 06/2002
4Atherosclerosis
05/2017 - 01/2011
4Carotid Artery Diseases
10/2012 - 07/2010
4Atherosclerotic Plaque (Atheroma)
12/2011 - 03/2007
3Lung Injury
01/2022 - 01/2016
3Uveal melanoma
05/2021 - 09/2020
3Ischemia
05/2021 - 09/2008
3Kidney Diseases (Kidney Disease)
01/2020 - 07/2010
3Cardiovascular Diseases (Cardiovascular Disease)
08/2017 - 11/2008
3Disease Progression
03/2017 - 07/2011
3Lymphatic Metastasis
01/2017 - 03/2010
3Infections
01/2014 - 03/2010
3Pain (Aches)
08/2013 - 02/2011
3Liver Diseases (Liver Disease)
12/2012 - 05/2007
2Pneumonia (Pneumonitis)
01/2022 - 01/2020
2Hepatocellular Carcinoma (Hepatoma)
01/2021 - 08/2006
2Triple Negative Breast Neoplasms
05/2019 - 10/2018
2Adenoma (Adenomas)
03/2018 - 01/2018
2Glioma (Gliomas)
01/2018 - 06/2015
2Neuroblastoma
05/2017 - 12/2014
2Sepsis (Septicemia)
01/2014 - 11/2004
2Adenocarcinoma of Lung
10/2012 - 06/2002

Drug/Important Bio-Agent (IBA)

42Proteins (Proteins, Gene)FDA Link
03/2022 - 06/2002
25Biomarkers (Surrogate Marker)IBA
04/2022 - 10/2009
21LigandsIBA
05/2022 - 06/2002
12AntigensIBA
09/2021 - 06/2008
12PPAR gammaIBA
10/2012 - 06/2002
11EphrinsIBA
05/2022 - 08/2013
11Histone Deacetylase InhibitorsIBA
03/2022 - 10/2011
11Pharmaceutical PreparationsIBA
03/2022 - 02/2011
9Histone Deacetylases (Histone Deacetylase)IBA
03/2022 - 02/2013
9Eph Family Receptors (Eph Receptors)IBA
02/2022 - 09/2011
8Biological ProductsIBA
01/2021 - 06/2002
6ParaffinIBA
10/2021 - 06/2008
5MicroRNAs (MicroRNA)IBA
04/2022 - 11/2016
5EnzymesIBA
08/2021 - 09/2008
4Pregnane X ReceptorIBA
10/2021 - 01/2013
4Messenger RNA (mRNA)IBA
09/2021 - 01/2015
4LipidsIBA
03/2021 - 01/2012
4Glucose (Dextrose)FDA LinkGeneric
01/2019 - 06/2002
4PaxillinIBA
09/2017 - 12/2014
4Focal Adhesion Protein-Tyrosine KinasesIBA
01/2017 - 12/2010
4CannabinoidsIBA
03/2016 - 01/2015
4EndocannabinoidsIBA
01/2016 - 04/2013
4Transcription Factors (Transcription Factor)IBA
09/2014 - 05/2009
3ErythropoietinFDA Link
05/2022 - 03/2022
3Histones (Histone)IBA
03/2022 - 10/2011
3CytokinesIBA
01/2022 - 01/2016
3Phosphotransferases (Kinase)IBA
12/2021 - 04/2015
3AntioxidantsIBA
05/2021 - 09/2008
3Immune Checkpoint InhibitorsIBA
05/2021 - 05/2019
3Antineoplastic Agents (Antineoplastics)IBA
01/2021 - 01/2014
3Bile Acids and Salts (Bile Acids)IBA
01/2019 - 01/2012
3Cyclooxygenase 2 (Cyclooxygenase-2)IBA
07/2018 - 01/2015
3Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2018 - 12/2011
3Retinoid X Receptors (Retinoid X Receptor)IBA
10/2015 - 05/2009
3Matrix Metalloproteinases (MMPs)IBA
04/2015 - 12/2008
3Peroxisome Proliferator-Activated Receptors (PPAR)IBA
11/2012 - 02/2011
3Toll-Like Receptors (Toll-Like Receptor)IBA
08/2010 - 11/2008
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
05/2022 - 08/2012
2tyrosine receptor (receptor, tyrosine)IBA
04/2022 - 12/2021
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2022 - 08/2006
2Interleukin-6 (Interleukin 6)IBA
01/2022 - 01/2016
2ELAV-Like Protein 1IBA
01/2022 - 01/2021
2Phenobarbital (Luminal)FDA Link
10/2021 - 07/2018
2RNA-Binding Proteins (RNA-Binding Protein)IBA
09/2021 - 07/2018
2CarcinogensIBA
01/2021 - 06/2006
2AzoxymethaneIBA
10/2020 - 06/2018
2Dextran SulfateIBA
10/2020 - 06/2018
2CD40 Ligand (CD40L)IBA
10/2020 - 01/2018
2Cyclin EIBA
11/2019 - 05/2009
2Retinoblastoma ProteinIBA
11/2019 - 09/2003
2CyclinsIBA
11/2019 - 09/2003
2AdipokinesIBA
01/2019 - 01/2018
2Antigen Receptors (Antigen Receptor)IBA
07/2018 - 01/2015
2LeptinIBA
01/2018 - 05/2007
2C-Reactive ProteinIBA
01/2018 - 01/2014
2Cannabinoid Receptors (Cannabinoid Receptor)IBA
01/2016 - 04/2013
2GhrelinIBA
04/2014 - 04/2013
2Thioacetamide (Thioacetamid)IBA
12/2012 - 09/2008

Therapy/Procedure

22Therapeutics
06/2022 - 04/2006
11Drug Therapy (Chemotherapy)
05/2022 - 11/2004
5Immunotherapy
05/2021 - 05/2019
2Endoscopes
09/2022 - 06/2022